Search for media from: "Denise Croix"

Understanding the Current Standard of Care in Cervical Cancer Screening

Dr. Linda Ahn from Roche Medical and Scientific Affairs team discusses the current standard of care in cervical cancer screening. Part 1 of a 4 part series. Content and approvals of any product…

From  Denise Croix 1 likes 31 plays

Introduction to IMPACT Trial data

Dr. Linda Ahn from Roche Medical and Scientific Affairs team provides an introduction to the IMPACT trial data for use of biomarkers in cervical cancer triage. Part 2 of a 4 part series. Content…

From  Denise Croix 1 likes 32 plays

Cell Cycle Deregulation Biomarkers

Dr. Beatrice Wegrzyniak of Roche medical and scientific affairs team discusses the biomarkers that indicate cell cycle deregulation in cervical cancer screening. Part 3 of a 4 part series. Content…

From  Denise Croix 1 likes 23 plays

CINtec PLUS Cytology Assay Interpretation

Dr. Beatrice Wegrzyniak of Roche medical and scientific affairs provides an overview of interpretation of the CINtec PLUS Cytology Assay for cervical cancer triage. Part 4 of a 4 part series. …

From  Denise Croix 0 likes 16 plays

MSA Ventana HER2 Dual ISH

Dr. Beatrice Wegrzyniak from the Roche Diagnostics US Medical and Scientific Affairs team provides an overview of the new Ventana HER2 Dual ISH assay, comparison to the original assay and examples of…

From  Denise Croix 0 likes 6 plays

MSA SP263 Immune Cell Scoring Part 1 of 3

Dr. Lupe Manriquez from the Roche Medical and Scientific Affairs team discusses immune cell scoring utilizing the SP263 assay. This is part 1 of a 3 part series Veeva #TE-US-01058

From  Denise Croix 0 likes 2 plays

MSA SP263 Immune Cell Scoring Part 2 of 3

Dr. Lupe Manriquez from the Roche Medical and Scientific Affairs team discusses immune cell scoring utilizing the SP263 assay. This is part 2 of a 3 part series. Veeva TE-US-01057

From  Denise Croix 0 likes 0 plays 0  

MSA SP263 Immune Cell Scoring Part 3 of 3

Dr. Lupe Manriquez from Roche Diagnostics MSA discusses SP263 immune cell scoring. This is part 3 of a 3 part series. Veeva TE-US-01059

From  Denise Croix 0 likes 1 plays

Risk Management of HPV+ Women: The case for integrating p16/Ki-67 dual stain .

Dr. Tom Wright is an internationally recognized expert who has been instrumental in key clinical trials driving the development of novel diagnostics in the field of cervical cancer. In his 48…

From  Denise Croix 1 likes 21 plays

Artificially Intelligent Clinical Decision Support: Where are we going and how do we get there?

Join the Roche Medical Affairs team discussing the role of artificial intelligence in clinical decision support. This workshop previously presented at USCAP 2021. Veeva MC-US-08974

From  Denise Croix 0 likes 8 plays 0  

Ventana PD-L1 SP263 Educational Video Module 1

Dr. Dorothy Hayden, a pathologist with Roche Diagnostics, provides a brief overview of the Ventana PD-L1 (SP263) assay & staining in non-small cell lung carcinoma (NSCLC) specimens. Please note…

From  Denise Croix 0 likes 2 plays

Ventana PD-L1 SP263 Educational Video Module 2

Dr. Dorothy Hayden, a pathologist with Roche Diagnostics, provides instruction on evaluating the Ventana PD-L1 (SP263) assay in non-small cell lung carcinoma (NSCLC) cases. This is part 2 of a 3…

From  Denise Croix 0 likes 1 plays

Ventana PD-L1 SP263 Educational Video Module 3

Dr. Dorothy Hayden, a pathologist with Roche Diagnostics, provides a guided digital review of non-small cell lung carcinoma (NSCLC) specimens stained with the Ventana PD-L1 (SP263) Assay. This is…

From  Denise Croix 0 likes 1 plays